These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 28320259

  • 1. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabrò MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A, CHEETAH Study Group.
    N Engl J Med; 2017 May 25; 376(21):2021-2031. PubMed ID: 28320259
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH, LEVO-CTS Investigators.
    N Engl J Med; 2017 May 25; 376(21):2032-2042. PubMed ID: 28316276
    [Abstract] [Full Text] [Related]

  • 3. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillion A, Boyer J, Boughenou MF, Rosier S, Robin E, Radutoiu M, Durand M, Guidon C, Desebbe O, Charles-Nelson A, Menasché P, Rozec B, Girard C, Fellahi JL, Pirracchio R, Chatellier G, -.
    JAMA; 2017 Aug 08; 318(6):548-556. PubMed ID: 28787507
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A, Alvaro G, Pisano A, Guarracino F, Lobreglio R, Bradic N, Lembo R, Gianni S, Calabrò MG, Likhvantsev V, Grigoryev E, Buscaglia G, Pala G, Auci E, Amantea B, Monaco F, De Vuono G, Corcione A, Galdieri N, Cariello C, Bove T, Fominskiy E, Auriemma S, Baiocchi M, Bianchi A, Frontini M, Paternoster G, Sangalli F, Wang CY, Zucchetti MC, Biondi-Zoccai G, Gemma M, Lipinski MJ, Lomivorotov VV, Landoni G.
    Am Heart J; 2016 Jul 08; 177():66-73. PubMed ID: 27297851
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J, Rücker G, Stiller B.
    Cochrane Database Syst Rev; 2017 Mar 06; 3(3):CD011312. PubMed ID: 28262914
    [Abstract] [Full Text] [Related]

  • 6. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.
    Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE.
    Intensive Care Med; 2012 Jul 06; 38(7):1198-204. PubMed ID: 22527079
    [Abstract] [Full Text] [Related]

  • 7. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 06; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 8. Early levosimendan administration is associated with decreased mortality after cardiac surgery.
    Treskatsch S, Balzer F, Geyer T, Spies CD, Kastrup M, Grubitzsch H, Wernecke KD, Erb JM, Braun JP, Sander M.
    J Crit Care; 2015 Aug 06; 30(4):859.e1-6. PubMed ID: 25837801
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J, Rücker G, Stiller B.
    Cochrane Database Syst Rev; 2017 Aug 02; 8(8):CD011312. PubMed ID: 28770972
    [Abstract] [Full Text] [Related]

  • 10. Preoperative levosimendan in ischemic mitral valve repair.
    Sharma P, Malhotra A, Gandhi S, Garg P, Bishnoi A, Gandhi H.
    Asian Cardiovasc Thorac Ann; 2014 Jun 02; 22(5):539-45. PubMed ID: 24867027
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial.
    Wang A, Cui C, Fan Y, Zi J, Zhang J, Wang G, Wang F, Wang J, Tan Q.
    Crit Care; 2019 Dec 30; 23(1):428. PubMed ID: 31888711
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
    Sanfilippo F, Knight JB, Scolletta S, Santonocito C, Pastore F, Lorini FL, Tritapepe L, Morelli A, Arcadipane A.
    Crit Care; 2017 Oct 19; 21(1):252. PubMed ID: 29047417
    [Abstract] [Full Text] [Related]

  • 13. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J, Taboada M, Rodríguez J, Caruezo V, Bouzada M, Campaña O, Bascuas B, Pérez-Paz J, Ginesta V.
    Rev Esp Anestesiol Reanim; 2005 Oct 19; 52(7):389-94. PubMed ID: 16200918
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
    Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, Singer M.
    Br J Anaesth; 2009 Feb 19; 102(2):198-204. PubMed ID: 19151048
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
    Tasouli A, Papadopoulos K, Antoniou T, Kriaras I, Stavridis G, Degiannis D, Geroulanos S.
    Eur J Cardiothorac Surg; 2007 Oct 19; 32(4):629-33. PubMed ID: 17702589
    [Abstract] [Full Text] [Related]

  • 16. First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
    Osthaus WA, Boethig D, Winterhalter M, Huber D, Goerler H, Sasse M, Sümpelmann R.
    Eur J Pediatr; 2009 Jun 19; 168(6):735-40. PubMed ID: 18813947
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan increases bleeding risk after heart valve surgery: a retrospective analysis of a randomized trial.
    Lahtinen P, Pitkänen O, Musialowicz T.
    J Cardiothorac Vasc Anesth; 2014 Oct 19; 28(5):1238-42. PubMed ID: 25281042
    [Abstract] [Full Text] [Related]

  • 18. Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
    Lim JY, Deo SV, Rababa'h A, Altarabsheh SE, Cho YH, Hang D, McGraw M, Avery EG, Markowitz AH, Park SJ.
    J Card Surg; 2015 Jul 19; 30(7):547-54. PubMed ID: 25989324
    [Abstract] [Full Text] [Related]

  • 19. [Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions].
    Lobacheva GV, Khar'kin AV, Manerova AF, Dzhobava ER.
    Anesteziol Reanimatol; 2010 Jul 19; (5):23-7. PubMed ID: 21400728
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
    Anastasiadis K, Antonitsis P, Vranis K, Kleontas A, Asteriou C, Grosomanidis V, Tossios P, Argiriadou H.
    Interact Cardiovasc Thorac Surg; 2016 Nov 19; 23(5):740-747. PubMed ID: 27378790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.